Imperial researchers will receive almost £15m in funding to embark on cutting edge research to help overcome neurodegenerative disease.The four Imperial-led projects are among 18 projects funded by ...

Motif’s BCI technology is designed to monitor and regulate mental and cognitive states without a need for brain surgery.

Motif Neurotech, a Houston-based neurotechnology company, today announced their selection by UK’s Advanced Research and ...

A pioneering NHS trial is set to explore the potential of a brain-computer interface (BCI) that uses ultrasound to alter ...

Barking, Havering and Redbridge University Hospitals NHS Trust will trial a whole-brain computer interface to modulate ...

Motif Neurotech has received a multi-million dollar grant to support the development of a therapeutic brain-computer ...

The £6.5 million clinical trial of neurotechnology, funded by the UK’s Advanced Research and Invention Agency, will test the safety and tolerability of the technology on 30 patients.

The innovative tech, designed by US-based non-profit Forest Neurotech, would improve patients' moods by directly altering ...

To its credit, the government has set up programs like the Advanced Research and Invention Agency (ARIA), modeled after the ...

Motif Neurotech, a Houston-based neurotechnology company, today announced their selection by UK’s Advanced Research and Invention Agency (ARIA) for multimillion dollar award to support Motif’s ...